[Trends in the study of genetic engineering in cardiovascular diseases].
D000595:Amino Acid Sequence; D000808:Angiotensinogen / Q000235:genetics; D001059:Apoproteins / Q000235:genetics; D001161:Arteriosclerosis / Q000209:etiology*; D009320:Atrial Natriuretic Factor / Q000502:physiology; D003001:Cloning, Molecular; D004247:DNA; D005818:Genetic Engineering / Q000379:methods; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000150:complications; D006952:Hyperlipoproteinemia Type III / Q000209:etiology; D006973:Hypertension / Q000209:etiology; D009218:Myosins / Q000235:genetics; D011956:Receptors, Cell Surface / Q000172:deficiency; D018110:Receptors, Lipoprotein; D000254:Sodium-Potassium-Exchanging ATPase / Q000502:physiology
D001059:Apoproteins; D011956:Receptors, Cell Surface; D018110:Receptors, Lipoprotein; D000808:Angiotensinogen; D009320:Atrial Natriuretic Factor; D004247:DNA; D009218:Myosins; D000254:Sodium-Potassium-Exchanging ATPase